The transatlantic medtech investment gap: why does it exist and can it be closed?
The medical technology sector has long been characterized as the constant and reliable driver of the world of life sciences. A sector that offers steady growth, without the wild volatility and boom-or-bust narratives of biotech or the frothy hype of digital health, may be seen by some as “vanilla,” but it also has the benefit…